Antiviral combination therapies for persistent COVID-19 in immunocompromised patients
Objectives: After the third year of the COVID-19 pandemic, most of the severe COVID-19 burden falls upon immunocompromised patients who cannot mount an endogenous immune response after both vaccination and/or natural infection. They also experience persistent SARS-CoV-2 infection with high viral loa...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2023-12-01
|
| Serie: | International Journal of Infectious Diseases |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S1201971223007348 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|